Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation

BACKGROUND: New therapeutic targets for cardiac hypertrophy, an independent risk factor for heart failure and death, are essential. HNO is a novel redox sibling of NO• attracting considerable attention for the treatment of cardiovascular disorders, eliciting cGMP-dependent vasodilatation yet cGMP-in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lin, Eliane Q., Irvine, Jennifer C., Cao, Anh H., Alexander, Amy E., Love, Jane E., Patel, Ruchi, McMullen, Julie R., Kaye, David M., Kemp-Harper, Barbara K., Ritchie, Rebecca H.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3323591/
https://ncbi.nlm.nih.gov/pubmed/22506056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0034892
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars